Breaking News, Promotions & Moves

TORL BioTherapeutics Appoints Aran Maree as Chief Medical Officer

Maree boasts a long track record of improving patient outcomes in multiple disease categories and creating corporate value.

Author Image

By: Charlie Sternberg

Associate Editor

TORL BioTherapeutics LLC, a clinical stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend the lives of patients with cancer worldwide, has appointed Aran Maree, MD, as Chief Medical Officer.   Dr. Maree most recently served as Chief Medical Officer for Johnson & Johnson (J&J) Innovative Medicines where he oversaw a functionally independent team with a primary focus on clinical and scientific advancement of the established produ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters